Mike Hennessy Sr, Founder and Chairman, MJH Life Sciences | Authors

Precision Medicine Takes Center Stage in GI Cancer

March 19, 2021

In order to properly utilize cancer therapies for personalized care, adequate molecular testing must be performed in patients who are eligible for these therapies, with this necessity becoming more and more prevalent in the treatment of gastrointestinal malignancies.